Detalhe da pesquisa
1.
Adsorption Studies of Organophosphonic Acids on Differently Activated Gold Surfaces.
Langmuir
; 32(6): 1550-9, 2016 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26811882
2.
Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell-engaging CD19/CD3-bispecific BiTE antibody blinatumomab.
Blood
; 119(26): 6226-33, 2012 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-22592608
3.
Rigidity-Induced Controlled Aggregation of Binary Colloids.
ACS Omega
; 8(40): 37225-37232, 2023 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37841185
4.
Dynamic topological domain walls driven by lithium intercalation in graphene.
Nat Nanotechnol
; 18(10): 1154-1161, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37488219
5.
Characterization and root cause analysis of immunogenicity to pasotuxizumab (AMG 212), a prostate-specific membrane antigen-targeting bispecific T-cell engager therapy.
Front Immunol
; 14: 1261070, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37942314
6.
Preclinical Assessment of a MUC12-Targeted BiTE (Bispecific T-cell Engager) Molecule.
Mol Cancer Ther
; 20(10): 1977-1987, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34376583
7.
Adhesion of T Cells to Endothelial Cells Facilitates Blinatumomab-Associated Neurologic Adverse Events.
Cancer Res
; 80(1): 91-101, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31662326
8.
Blinatumomab Pharmacodynamics and Exposure-Response Relationships in Relapsed/Refractory Acute Lymphoblastic Leukemia.
J Clin Pharmacol
; 58(2): 168-179, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28922466
9.
Self-Healing and Shape Memory Effects in Gold Microparticles through the Defects-Mediated Diffusion.
Adv Sci (Weinh)
; 4(8): 1700159, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28852628
10.
In situ observation of deformation processes in nanocrystalline face-centered cubic metals.
Beilstein J Nanotechnol
; 7: 572-80, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27335747
11.
Blinatumomab, a Bispecific T-cell Engager (BiTE(®)) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its Implications.
Clin Pharmacokinet
; 55(10): 1271-1288, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27209293
12.
Regression of human prostate cancer xenografts in mice by AMG 212/BAY2010112, a novel PSMA/CD3-Bispecific BiTE antibody cross-reactive with non-human primate antigens.
Mol Cancer Ther
; 11(12): 2664-73, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23041545
13.
Combination of rituximab with blinatumomab (MT103/MEDI-538), a T cell-engaging CD19-/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cells.
Leuk Res
; 33(3): 465-73, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18835037
14.
Tumor regression in cancer patients by very low doses of a T cell-engaging antibody.
Science
; 321(5891): 974-7, 2008 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18703743
15.
The effect of dexamethasone on polyclonal T cell activation and redirected target cell lysis as induced by a CD19/CD3-bispecific single-chain antibody construct.
Cancer Immunol Immunother
; 56(10): 1551-63, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17310380
16.
T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct.
Cancer Immunol Immunother
; 55(5): 503-14, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16032400
17.
Serial killing of tumor cells by cytotoxic T cells redirected with a CD19-/CD3-bispecific single-chain antibody construct.
Int J Cancer
; 115(1): 98-104, 2005 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-15688411
18.
Mas-allatotropin/Lom-AG-myotropin I immunostaining in the brain of the locust, Schistocerca gregaria.
Cell Tissue Res
; 318(2): 439-57, 2004 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-15480799
19.
Extremely potent, rapid and costimulation-independent cytotoxic T-cell response against lymphoma cells catalyzed by a single-chain bispecific antibody.
Int J Cancer
; 100(6): 690-7, 2002 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-12209608